ASGN (EFOR) Financials

$19.00 +1.04 (+5.79%)

As of 05/18/2026 03:58 PM Eastern

Annual Income Statements for ASGN

This table shows ASGN's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	94	95	164	155	174	200	411	266	222	170	117
Consolidated Net Income / (Loss)	98	97	158	158	175	200	410	268	219	175	114
Net Income / (Loss) Continuing Operations	71	97	158	158	150	178	232	267	219	175	114
Total Pre-Tax Income	122	157	197	204	204	242	313	364	298	240	163
Total Operating Income	152	190	225	260	276	281	351	410	364	304	230
Total Gross Profit	679	795	850	1,024	972	947	1,142	1,370	1,280	1,184	1,149
Total Revenue	2,065	2,440	2,626	3,400	3,416	3,502	4,010	4,581	4,451	4,100	3,980
Operating Revenue	2,065	2,440	2,626	3,400	3,416	3,502	4,010	4,581	4,451	4,100	3,980
Total Cost of Revenue	1,386	1,645	1,776	2,376	2,444	2,555	2,867	3,212	3,171	2,916	2,831
Operating Cost of Revenue	1,386	1,645	1,776	2,376	2,444	2,555	2,867	3,212	3,171	2,916	2,831
Total Operating Expenses	527	605	625	764	695	666	792	960	916	879	919
Selling, General & Admin Expense	492	566	592	705	645	615	736	895	844	821	854
Amortization Expense	34	40	33	59	50	51	56	65	72	58	65
Total Other Income / (Expense), net	-30	-32	-28	-56	-72	-40	-38	-46	-66	-64	-68
Interest Expense	30	32	28	56	72	40	38	46	66	64	68
Income Tax Expense	50	60	39	46	55	64	82	97	78	65	49
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	3.71	1.86	-6.50	2.70	0.70	-	-0.70	2.40	-2.70	5.00	-3.40
Basic Earnings per Share	$3.74	$1.83	$3.01	$3.02	$3.31	$3.80	$7.78	$5.30	$4.54	$3.88	$2.62
Weighted Average Basic Shares Outstanding	52.26M	53.19M	52.50M	52.30M	52.80M	52.70M	52.70M	50.60M	48.30M	45.20M	43.40M
Diluted Earnings per Share	$3.68	$1.81	$2.97	$2.98	$3.28	$3.76	$7.66	$5.23	$4.50	$3.83	$2.60
Weighted Average Diluted Shares Outstanding	53.01M	53.75M	53.20M	53.10M	53.40M	53.30M	53.50M	51.30M	48.70M	45.70M	43.60M
Weighted Average Basic & Diluted Shares Outstanding	52.20M	53.10M	52.40M	52.66M	53M	53M	51.60M	49.30M	46.50M	43.60M	41.30M

This table shows ASGN's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	58	52	38	49	48	35	22	32	38	26	4.80
Consolidated Net Income / (Loss)	59	50	38	47	48	42	21	29	38	25	5.50
Net Income / (Loss) Continuing Operations	59	50	38	47	48	42	21	29	38	25	5.50
Total Pre-Tax Income	80	67	53	65	63	59	31	41	51	40	11
Total Operating Income	99	83	71	80	79	74	47	60	68	56	28
Total Gross Profit	322	305	296	301	300	286	275	293	297	284	267
Total Revenue	1,117	1,074	1,049	1,035	1,031	985	968	1,021	1,011	980	968
Operating Revenue	1,117	1,074	1,049	1,035	1,031	985	968	1,021	1,011	980	968
Total Cost of Revenue	794	769	753	734	731	699	693	727	715	697	702
Operating Cost of Revenue	794	769	753	734	731	699	693	727	715	697	702
Total Operating Expenses	224	222	225	221	222	212	229	234	229	227	239
Selling, General & Admin Expense	206	204	210	206	208	198	215	217	212	211	224
Amortization Expense	18	18	15	15	14	14	14	17	17	17	15
Total Other Income / (Expense), net	-19	-17	-18	-16	-16	-15	-15	-18	-17	-17	-17
Interest Expense	19	17	18	16	16	15	15	18	17	17	17
Income Tax Expense	21	16	15	17	15	17	10	12	12	14	5.10
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	1.30	-1.60	0.20	-2.10	-0.20	7.10	-0.80	-2.60	0.40	-0.40	0.70
Basic Earnings per Share	$1.23	$1.08	$0.82	$1.03	$1.07	$0.96	$0.48	$0.67	$0.88	$0.59	$0.13
Weighted Average Basic Shares Outstanding	48.10M	48.30M	46.50M	45.70M	44.50M	45.20M	43.70M	43.80M	43.50M	43.40M	41.30M
Diluted Earnings per Share	$1.23	$1.06	$0.81	$1.02	$1.06	$0.94	$0.48	$0.67	$0.87	$0.58	$0.13
Weighted Average Diluted Shares Outstanding	48.40M	48.70M	46.90M	46.10M	45M	45.70M	44M	44M	43.70M	43.60M	41.40M
Weighted Average Basic & Diluted Shares Outstanding	47.20M	46.50M	45.90M	44.80M	44.20M	43.60M	43.80M	43.80M	42.70M	41.30M	41M

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-7.85	3.18	9.60	5.10	53	179	255	-459	106	29	-44
Net Cash From Operating Activities	124	199	196	287	313	425	194	308	457	400	328
Net Cash From Continuing Operating Activities	124	199	196	287	313	425	194	308	457	400	328
Net Income / (Loss) Continuing Operations	72	97	158	158	175	200	410	268	219	175	114
Consolidated Net Income / (Loss)	98	97	158	158	175	200	410	268	219	175	114
Depreciation Expense	52	62	59	95	91	90	90	91	100	96	114
Non-Cash Adjustments To Reconcile Net Income	46	41	46	50	74	38	-158	58	54	51	60
Changes in Operating Assets and Liabilities, net	-45	-1.49	-66	-15	-27	97	-148	-109	83	77	41
Net Cash From Investing Activities	-462	-22	-50	-789	-149	-219	247	-510	-41	-35	-344
Net Cash From Continuing Investing Activities	-462	-22	-50	-789	-149	-219	247	-510	-41	-35	-344
Purchase of Property, Plant & Equipment	-25	-27	-24	-29	-33	-33	-35	-38	-40	-35	-40
Acquisitions	-553	0.00	-26	-760	-116	-186	-223	-485	0.00	0.00	-304
Other Investing Activities, net	0.50	-0.85	0.10	0.20	0.00	-0.20	0.20	2.30	-0.60	0.00	0.00
Net Cash From Financing Activities	331	-174	-139	508	-111	-29	-184	-257	-311	-333	-29
Net Cash From Continuing Financing Activities	333	-174	-139	508	-111	-29	-184	-257	-311	-333	-29
Repayment of Debt	-540	-130	-108	-318	-744	-67	-1.40	-71	-610	-7.40	-286
Repurchase of Common Equity	-1.65	-41	-60	0.00	-20	-28	-181	-281	-273	-327	-170
Issuance of Debt	875	11	37	822	653	66	0.00	94	572	0.00	421
Issuance of Common Equity	6.59	9.76	7.80	9.40	13	12	14	19	19	17	14
Other Financing Activities, net	-6.65	-7.02	-15	-5.60	-12	-12	-16	-17	-18	-16	-8.60
Effect of Exchange Rate Changes	-1.47	-0.11	1.80	-1.40	-0.20	2.40	-0.60	-0.60	0.10	-2.20	1.40
Cash Interest Paid	22	27	24	51	45	38	35	44	62	63	67
Cash Income Taxes Paid	45	38	55	21	57	64	170	55	45	34	7.90

This table details how cash moves in and out of ASGN's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	52	30	-18	-26	34	39	-98	32	-12	35	-18
Net Cash From Operating Activities	148	116	73	91	136	100	17	125	84	102	19
Net Cash From Continuing Operating Activities	148	116	73	91	136	100	17	125	84	102	19
Net Income / (Loss) Continuing Operations	59	50	38	47	48	42	21	29	38	25	5.50
Consolidated Net Income / (Loss)	59	50	38	47	48	42	21	29	38	25	5.50
Depreciation Expense	25	26	25	25	23	24	26	29	29	30	28
Non-Cash Adjustments To Reconcile Net Income	16	11	15	14	12	11	20	13	13	14	17
Changes in Operating Assets and Liabilities, net	47	29	-4.10	5.50	53	23	-50	54	3.50	33	-32
Net Cash From Investing Activities	-9.80	-7.20	-11	-5.20	-8.00	-11	-316	-9.10	-12	-6.60	-293
Net Cash From Continuing Investing Activities	-9.80	-7.20	-11	-5.20	-8.00	-11	-316	-9.10	-12	-6.60	-293
Purchase of Property, Plant & Equipment	-9.80	-7.20	-11	-5.30	-7.90	-11	-10	-9.10	-12	-8.60	-9.40
Acquisitions	-	-	0.00	-	-	-	-306	-	-	2.00	-284
Net Cash From Financing Activities	-86	-79	-80	-111	-93	-50	201	-85	-85	-61	258
Net Cash From Continuing Financing Activities	-86	-79	-80	-111	-93	-50	201	-85	-85	-61	258
Repayment of Debt	-499	-1.30	-1.30	-1.20	-1.30	-3.60	-16	-74	-143	-52	-57
Repurchase of Common Equity	-91	-75	-80	-108	-96	-44	-50	-9.50	-46	-64	-39
Issuance of Debt	499	-	0.00	-	-	-	265	-	100	56	350
Issuance of Common Equity	7.80	-	9.50	-	7.70	-	8.70	-	5.50	-	6.90
Other Financing Activities, net	-1.50	-2.60	-8.50	-1.50	-3.70	-2.10	-5.80	-1.20	-0.80	-0.80	-3.40
Effect of Exchange Rate Changes	-0.30	0.40	0.00	-1.00	-0.50	-0.70	0.10	1.00	0.10	0.20	-0.70
Cash Interest Paid	9.30	23	9.80	22	9.60	21	9.10	24	11	23	10
Cash Income Taxes Paid	4.00	33	1.50	12	9.70	11	1.90	3.10	1.60	1.30	-4.00

This table presents ASGN's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,767	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Total Current Assets	414	438	500	686	792	994	1,309	981	973	918	916
Cash & Equivalents	24	-	37	42	95	274	530	70	176	205	161
Accounts Receivable	355	387	429	614	649	603	708	854	742	651	674
Other Current Assets	23	17	16	19	18	17	30	17	19	62	81
Plant, Property, & Equipment, net	53	57	58	79	74	55	55	66	81	83	85
Total Noncurrent Assets	1,300	1,258	1,253	1,922	2,076	2,229	2,138	2,538	2,490	2,429	2,677
Goodwill	875	874	894	1,421	1,487	1,421	1,570	1,892	1,894	1,893	2,143
Intangible Assets	418	378	353	489	477	470	488	570	498	440	454
Other Noncurrent Operating Assets	7.07	6.96	5.75	13	113	94	81	77	98	96	80
Total Liabilities & Shareholders' Equity	1,767	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Total Liabilities	983	884	819	1,506	1,565	1,691	1,637	1,684	1,653	1,652	1,873
Total Current Liabilities	160	162	167	308	341	416	451	442	394	367	424
Accounts Payable	9.13	6.27	6.87	43	39	38	20	35	34	27	47
Current Employee Benefit Liabilities	103	127	130	212	203	239	306	285	237	218	231
Other Current Liabilities	47	28	29	50	99	100	125	122	124	122	146
Total Noncurrent Liabilities	822	721	652	1,198	1,224	1,275	1,187	1,243	1,258	1,285	1,449
Long-Term Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Noncurrent Deferred & Payable Income Tax Liabilities	62	74	69	80	99	109	89	129	156	188	237
Other Noncurrent Operating Liabilities	5.12	6.59	7.37	17	93	121	64	47	66	64	42
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Total Preferred & Common Equity	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	785	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Common Stock	543	563	567	602	639	662	691	704	697	685	714
Retained Earnings	250	316	428	586	745	926	1,174	1,200	1,196	1,097	1,092
Accumulated Other Comprehensive Income / (Loss)	-8.16	-10	-3.64	-6.30	-7.00	-1.00	-0.30	-2.70	0.00	-5.00	-1.60

This table presents ASGN's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	3,611	3,525	3,561	3,579	3,489	3,451	3,432	3,698	3,715	3,700	4,028
Total Current Assets	1,120	927	972	994	933	914	907	880	916	918	970
Cash & Equivalents	211	65	94	146	158	132	167	107	139	127	144
Accounts Receivable	878	823	829	805	725	721	686	705	691	710	744
Other Current Assets	16	16	16	18	19	18	18	85	86	82	82
Plant, Property, & Equipment, net	62	72	76	79	83	79	79	80	83	83	81
Total Noncurrent Assets	2,429	2,527	2,513	2,506	2,473	2,458	2,445	2,799	2,715	2,699	2,976
Goodwill	1,806	1,894	1,894	1,894	1,894	1,894	1,894	2,140	2,141	2,142	2,281
Intangible Assets	545	552	534	516	483	468	454	504	488	471	613
Other Noncurrent Operating Assets	78	82	85	97	96	96	97	156	87	86	82
Total Liabilities & Shareholders' Equity	3,611	3,525	3,561	3,579	3,489	3,451	3,432	3,698	3,715	3,700	4,028
Total Liabilities	1,722	1,602	1,635	1,670	1,627	1,643	1,657	1,905	1,888	1,867	2,239
Total Current Liabilities	492	386	417	443	372	390	404	372	435	462	462
Accounts Payable	34	34	24	32	26	23	26	24	-	-	63
Current Employee Benefit Liabilities	329	252	267	251	233	233	237	211	246	249	251
Other Current Liabilities	130	100	126	160	113	134	141	180	189	213	148
Total Noncurrent Liabilities	1,230	1,216	1,218	1,227	1,256	1,253	1,254	1,578	1,454	1,405	1,777
Long-Term Debt	1,081	1,035	1,036	1,038	1,036	1,035	1,034	1,283	1,212	1,166	1,462
Noncurrent Deferred & Payable Income Tax Liabilities	98	129	129	131	156	156	156	191	192	192	275
Other Noncurrent Operating Liabilities	51	51	53	59	63	61	63	60	50	47	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,889	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789
Total Preferred & Common Equity	1,889	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,889	1,924	1,927	1,909	1,861	1,808	1,774	1,793	1,827	1,833	1,789
Common Stock	703	715	703	702	696	688	685	719	728	728	719
Retained Earnings	1,190	1,210	1,224	1,208	1,165	1,123	1,091	1,078	1,101	1,107	1,073
Accumulated Other Comprehensive Income / (Loss)	-4.20	-1.70	-0.30	-1.60	-0.20	-2.30	-2.10	-4.20	-1.60	-2.00	-2.30

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.73%	18.18%	7.60%	29.47%	0.46%	2.53%	14.49%	14.26%	-2.85%	-7.88%	-2.91%
EBITDA Growth	15.69%	23.64%	12.43%	25.38%	3.43%	0.95%	18.77%	13.71%	-7.29%	-13.72%	-14.20%
EBIT Growth	10.42%	24.63%	18.43%	15.80%	6.15%	1.81%	24.79%	16.70%	-11.09%	-16.40%	-24.34%
NOPAT Growth	10.05%	31.47%	53.65%	11.84%	0.47%	2.23%	25.50%	15.82%	-10.77%	-17.19%	-27.63%
Net Income Growth	26.52%	-0.46%	62.24%	0.00%	10.78%	14.65%	104.64%	-34.59%	-18.20%	-20.11%	-35.22%
EPS Growth	29.58%	-50.82%	64.09%	0.34%	10.07%	14.63%	103.72%	-31.72%	-13.96%	-14.89%	-32.11%
Operating Cash Flow Growth	29.18%	60.69%	-1.47%	46.33%	8.98%	35.63%	-54.40%	58.91%	48.44%	-12.45%	-18.03%
Free Cash Flow Firm Growth	-431.59%	130.75%	-12.57%	-484.99%	125.46%	242.90%	-107.82%	-553.86%	281.70%	-10.43%	-112.56%
Invested Capital Growth	62.16%	-2.25%	3.22%	46.46%	3.24%	-10.28%	14.18%	22.28%	-5.00%	-5.37%	7.95%
Revenue Q/Q Growth	7.08%	1.81%	2.27%	7.96%	-10.78%	7.97%	7.46%	2.15%	-1.69%	-2.13%	-0.12%
EBITDA Q/Q Growth	6.76%	1.20%	5.17%	6.74%	-6.75%	5.73%	6.22%	-0.12%	-1.67%	-2.67%	-3.37%
EBIT Q/Q Growth	4.85%	1.60%	7.11%	5.62%	-8.39%	7.00%	8.60%	-1.23%	-1.89%	-2.93%	-7.25%
NOPAT Q/Q Growth	3.36%	3.55%	35.63%	-9.48%	-9.06%	7.15%	9.24%	-2.06%	-1.21%	-4.26%	-9.65%
Net Income Q/Q Growth	-1.15%	5.07%	37.88%	-11.98%	-3.64%	8.74%	7.78%	-9.88%	-2.36%	-4.31%	-13.16%
EPS Q/Q Growth	-1.60%	-36.49%	118.38%	-11.83%	-4.09%	8.67%	7.89%	-26.96%	45.16%	-3.04%	-12.16%
Operating Cash Flow Q/Q Growth	7.53%	10.95%	0.92%	1.98%	5.95%	1.34%	-46.62%	104.79%	9.88%	-3.89%	0.64%
Free Cash Flow Firm Q/Q Growth	-19.63%	21.37%	2.87%	0.83%	-40.05%	288.39%	-109.23%	13.67%	79.89%	-5.25%	10.99%
Invested Capital Q/Q Growth	0.13%	-1.37%	1.52%	-0.11%	2.85%	-10.84%	8.28%	5.04%	-1.71%	-1.41%	-2.09%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.87%	32.58%	32.37%	30.11%	28.44%	27.05%	28.49%	29.90%	28.76%	28.87%	28.87%
EBITDA Margin	9.87%	10.33%	10.79%	10.45%	10.76%	10.59%	10.99%	10.93%	10.43%	9.77%	8.64%
Operating Margin	7.37%	7.77%	8.56%	7.65%	8.09%	8.03%	8.75%	8.94%	8.18%	7.42%	5.79%
EBIT Margin	7.37%	7.77%	8.56%	7.65%	8.09%	8.03%	8.75%	8.94%	8.18%	7.42%	5.79%
Profit (Net Income) Margin	4.73%	3.98%	6.01%	4.64%	5.11%	5.72%	10.22%	5.85%	4.93%	4.27%	2.85%
Tax Burden Percent	80.10%	61.75%	80.01%	77.23%	85.47%	82.94%	130.79%	73.73%	73.66%	72.97%	69.80%
Interest Burden Percent	80.08%	82.96%	87.72%	78.48%	74.00%	85.88%	89.31%	88.79%	81.76%	78.88%	70.60%
Effective Tax Rate	41.42%	38.25%	19.89%	22.62%	26.76%	26.46%	26.04%	26.60%	26.34%	27.03%	30.20%
Return on Invested Capital (ROIC)	7.27%	7.81%	11.95%	10.68%	8.88%	9.42%	11.68%	11.41%	9.49%	8.29%	5.94%
ROIC Less NNEP Spread (ROIC-NNEP)	8.92%	4.85%	8.08%	5.22%	6.12%	8.51%	41.97%	7.08%	4.23%	2.74%	0.79%
Return on Net Nonoperating Assets (RNNOA)	6.49%	3.94%	5.00%	3.83%	4.77%	4.09%	12.07%	2.82%	2.07%	1.26%	0.40%
Return on Equity (ROE)	13.76%	11.76%	16.95%	14.51%	13.66%	13.52%	23.75%	14.24%	11.56%	9.55%	6.34%
Cash Return on Invested Capital (CROIC)	-40.15%	10.09%	8.79%	-27.02%	5.70%	20.27%	-1.56%	-8.63%	14.62%	13.81%	-1.71%
Operating Return on Assets (OROA)	10.08%	10.78%	12.61%	11.57%	9.81%	9.04%	10.35%	11.55%	10.21%	8.73%	6.48%
Return on Assets (ROA)	6.47%	5.52%	8.85%	7.01%	6.21%	6.44%	12.09%	7.56%	6.15%	5.02%	3.19%
Return on Common Equity (ROCE)	13.76%	11.76%	16.95%	14.51%	13.66%	13.52%	23.75%	14.24%	11.56%	9.55%	6.34%
Return on Equity Simple (ROE_SIMPLE)	12.44%	11.19%	15.91%	13.34%	12.69%	12.62%	21.97%	14.10%	11.59%	9.86%	0.00%
Net Operating Profit after Tax (NOPAT)	89	117	180	201	202	207	260	301	268	222	161
NOPAT Margin	4.32%	4.80%	6.85%	5.92%	5.92%	5.90%	6.47%	6.56%	6.03%	5.42%	4.04%
Net Nonoperating Expense Percent (NNEP)	-1.65%	2.97%	3.87%	5.46%	2.76%	0.91%	-30.30%	4.33%	5.27%	5.56%	5.15%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	10.13%	9.16%	7.90%	5.41%
Cost of Revenue to Revenue	67.13%	67.42%	67.63%	69.89%	71.56%	72.95%	71.51%	70.10%	71.24%	71.13%	71.13%
SG&A Expenses to Revenue	23.83%	23.19%	22.54%	20.74%	18.88%	17.56%	18.35%	19.54%	18.97%	20.03%	21.46%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.50%	24.81%	23.82%	22.46%	20.36%	19.02%	19.74%	20.96%	20.58%	21.45%	23.08%
Earnings before Interest and Taxes (EBIT)	152	190	225	260	276	281	351	410	364	304	230
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	204	252	283	355	367	371	441	501	464	401	344
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.02	2.69	3.37	2.42	2.72	2.78	3.45	2.14	2.40	2.07	1.14
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.15	0.96	1.27	0.84	1.10	1.26	1.60	0.89	1.02	0.90	0.52
Price to Earnings (P/E)	25.23	24.52	20.36	18.45	21.54	22.06	15.66	15.30	20.45	21.64	17.60
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.96%	4.08%	4.91%	5.42%	4.64%	4.53%	6.39%	6.53%	4.89%	4.62%	5.68%
Enterprise Value to Invested Capital (EV/IC)	2.05	1.99	2.54	1.75	2.02	2.49	2.93	1.75	1.96	1.73	1.09
Enterprise Value to Revenue (EV/Rev)	1.50	1.21	1.48	1.15	1.37	1.48	1.73	1.11	1.21	1.10	0.77
Enterprise Value to EBITDA (EV/EBITDA)	15.24	11.71	13.70	11.03	12.75	13.96	15.74	10.11	11.63	11.26	8.92
Enterprise Value to EBIT (EV/EBIT)	20.40	15.55	17.27	15.06	16.96	18.41	19.76	12.36	14.83	14.82	13.31
Enterprise Value to NOPAT (EV/NOPAT)	34.84	25.19	21.56	19.46	23.16	25.04	26.71	16.84	20.13	20.31	19.07
Enterprise Value to Operating Cash Flow (EV/OCF)	25.03	14.80	19.76	13.63	14.96	12.19	35.79	16.45	11.82	11.28	9.35
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	19.50	29.33	0.00	36.12	11.64	0.00	0.00	13.07	12.20	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.96	0.74	0.58	0.93	0.75	0.65	0.55	0.56	0.55	0.58	0.65
Long-Term Debt to Equity	0.96	0.74	0.58	0.93	0.75	0.65	0.55	0.56	0.55	0.58	0.65
Financial Leverage	0.73	0.81	0.62	0.73	0.78	0.48	0.29	0.40	0.49	0.46	0.51
Leverage Ratio	2.13	2.13	1.92	2.07	2.20	2.10	1.96	1.88	1.88	1.90	1.98
Compound Leverage Factor	1.70	1.77	1.68	1.62	1.63	1.80	1.75	1.67	1.54	1.50	1.40
Debt to Total Capital	49.05%	42.43%	36.72%	48.21%	42.86%	39.44%	35.66%	35.94%	35.39%	36.78%	39.33%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	49.05%	42.43%	36.72%	48.21%	42.86%	39.44%	35.66%	35.94%	35.39%	36.78%	39.33%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	50.95%	57.57%	63.28%	51.79%	57.14%	60.56%	64.34%	64.06%	64.61%	63.22%	60.67%
Debt to EBITDA	3.71	2.54	2.03	3.10	2.81	2.79	2.35	2.13	2.23	2.58	3.40
Net Debt to EBITDA	3.59	2.43	1.90	2.98	2.55	2.05	1.14	1.99	1.85	2.07	2.93
Long-Term Debt to EBITDA	3.71	2.54	2.03	3.10	2.81	2.79	2.35	2.13	2.23	2.58	3.40
Debt to NOPAT	8.48	5.47	3.20	5.47	5.10	5.00	3.98	3.55	3.86	4.65	7.27
Net Debt to NOPAT	8.21	5.23	2.99	5.26	4.63	3.67	1.94	3.31	3.21	3.73	6.27
Long-Term Debt to NOPAT	8.48	5.47	3.20	5.47	5.10	5.00	3.98	3.55	3.86	4.65	7.27
Altman Z-Score	3.27	3.78	4.86	3.20	3.45	3.53	4.59	3.75	3.91	3.47	2.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.69	3.00	2.23	2.32	2.39	2.90	2.22	2.47	2.50	2.16
Quick Ratio	2.36	2.38	2.79	2.13	2.18	2.11	2.75	2.09	2.33	2.33	1.97
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-492	151	132	-509	130	445	-35	-227	413	370	-46
Operating Cash Flow to CapEx	502.43%	734.51%	808.23%	1,001.39%	957.80%	1,303.07%	558.21%	820.80%	1,145.11%	1,133.14%	823.87%
Free Cash Flow to Firm to Interest Expense	-16.30	4.68	4.79	-9.10	1.81	11.20	-0.93	-4.95	6.22	5.75	-0.69
Operating Cash Flow to Interest Expense	4.11	6.17	7.12	5.13	4.36	10.70	5.17	6.71	6.88	6.22	4.84
Operating Cash Flow Less CapEx to Interest Expense	3.29	5.33	6.24	4.62	3.91	9.88	4.24	5.89	6.28	5.67	4.26
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.37	1.39	1.47	1.51	1.21	1.13	1.18	1.29	1.25	1.18	1.12
Accounts Receivable Turnover	6.54	6.58	6.44	6.52	5.41	5.60	6.12	5.87	5.58	5.89	6.01
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	42.36	44.32	45.69	49.60	44.71	54.47	72.97	75.53	60.27	50.00	47.64
Accounts Payable Turnover	162.54	213.69	270.39	95.10	59.39	65.93	98.19	116.15	91.64	95.29	76.11
Days Sales Outstanding (DSO)	55.85	55.46	56.67	55.95	67.46	65.22	59.67	62.22	65.41	61.98	60.76
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	2.25	1.71	1.35	3.84	6.15	5.54	3.72	3.14	3.98	3.83	4.80
Cash Conversion Cycle (CCC)	53.60	53.76	55.32	52.11	61.31	59.68	55.96	59.08	61.43	58.15	55.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,516	1,482	1,530	2,241	2,313	2,075	2,370	2,898	2,753	2,605	2,812
Invested Capital Turnover	1.68	1.63	1.74	1.80	1.50	1.60	1.80	1.74	1.58	1.53	1.47
Increase / (Decrease) in Invested Capital	581	-34	48	711	73	-238	294	528	-145	-148	207
Enterprise Value (EV)	3,105	2,951	3,882	3,919	4,684	5,178	6,933	5,062	5,400	4,512	3,065
Market Capitalization	2,373	2,338	3,343	2,860	3,747	4,419	6,429	4,066	4,539	3,684	2,057
Book Value per Share	$14.86	$16.41	$19.06	$22.53	$26.06	$30.00	$35.80	$38.10	$40.09	$40.20	$42.25
Tangible Book Value per Share	($9.62)	($7.22)	($4.91)	($13.87)	($11.12)	($5.74)	($3.69)	($11.23)	($10.59)	($12.58)	($18.57)
Total Capital	1,540	1,509	1,567	2,283	2,409	2,621	2,899	2,968	2,929	2,810	2,973
Total Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Total Long-Term Debt	756	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Net Debt	732	613	539	1,059	937	759	504	996	861	828	1,008
Capital Expenditures (CapEx)	25	27	24	29	33	33	35	38	40	35	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	230	248	296	336	355	304	329	469	403	345	331
Debt-free Net Working Capital (DFNWC)	254	275	333	378	451	578	859	539	579	551	492
Net Working Capital (NWC)	254	275	333	378	451	578	859	539	579	551	492
Net Nonoperating Expense (NNE)	-8.54	20	22	44	28	6.50	-150	32	49	47	47
Net Nonoperating Obligations (NNO)	732	613	539	1,059	937	488	504	996	861	828	1,008
Total Depreciation and Amortization (D&A)	52	62	59	95	91	90	90	91	100	96	114
Debt-free, Cash-free Net Working Capital to Revenue	11.14%	10.16%	11.28%	9.89%	10.41%	8.67%	8.20%	10.24%	9.06%	8.43%	8.31%
Debt-free Net Working Capital to Revenue	12.29%	11.27%	12.67%	11.12%	13.19%	16.51%	21.41%	11.77%	13.01%	13.43%	12.36%
Net Working Capital to Revenue	12.29%	11.27%	12.67%	11.12%	13.19%	16.51%	21.41%	11.77%	13.01%	13.43%	12.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.74	$3.66	$6.02	$3.02	$3.31	$3.80	$7.78	$5.30	$4.54	$3.88	$2.62
Adjusted Weighted Average Basic Shares Outstanding	52.26M	53.19M	52.50M	52.33M	52.80M	52.70M	52.70M	50.60M	48.30M	45.20M	43.40M
Adjusted Diluted Earnings per Share	$3.68	$3.62	$5.94	$2.98	$3.28	$3.76	$7.66	$5.23	$4.50	$3.83	$2.60
Adjusted Weighted Average Diluted Shares Outstanding	53.01M	53.75M	53.21M	53.06M	53.40M	53.30M	53.50M	51.30M	48.70M	45.70M	43.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.20M	52.65M	52.18M	52.66M	53M	53M	51.60M	49.30M	46.50M	43.60M	41.30M
Normalized Net Operating Profit after Tax (NOPAT)	89	117	180	201	202	207	260	301	268	222	161
Normalized NOPAT Margin	4.32%	4.80%	6.85%	5.92%	5.92%	5.90%	6.47%	6.56%	6.03%	5.42%	4.04%
Pre Tax Income Margin	5.90%	6.45%	7.51%	6.01%	5.98%	6.90%	7.82%	7.94%	6.69%	5.86%	4.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.04	5.87	8.14	4.65	3.85	7.08	9.36	8.92	5.48	4.73	3.40
NOPAT to Interest Expense	2.95	3.62	6.52	3.60	2.82	5.21	6.92	6.55	4.04	3.45	2.37
EBIT Less CapEx to Interest Expense	4.22	5.03	7.26	4.13	3.39	6.26	8.43	8.10	4.88	4.19	2.81
NOPAT Less CapEx to Interest Expense	2.13	2.78	5.64	3.08	2.36	4.39	6.00	5.73	3.44	2.91	1.79
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	17.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.68%	59.58%	38.11%	0.00%	11.45%	13.93%	44.23%	104.96%	124.53%	186.76%	149.87%

This table displays calculated financial ratios and metrics derived from ASGN's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	41,300,000.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	41,300,000.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.12
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-6.77%	-6.63%	-7.07%	-8.51%	-7.68%	-8.30%	-7.69%	-1.36%	-1.90%	-0.50%	0.00%
EBITDA Growth	-7.50%	-6.75%	-12.56%	-14.58%	-17.10%	-10.08%	-24.32%	-15.82%	-4.99%	-12.23%	-22.85%
EBIT Growth	-9.04%	-7.74%	-15.80%	-17.88%	-19.98%	-11.03%	-34.27%	-25.87%	-13.94%	-24.26%	-40.56%
NOPAT Growth	-8.64%	-4.90%	-16.34%	-18.03%	-18.51%	-15.65%	-38.41%	-28.20%	-14.02%	-32.42%	-53.96%
Net Income Growth	-18.85%	-9.53%	-23.03%	-21.46%	-20.03%	-15.71%	-45.14%	-37.92%	-19.79%	-40.57%	-73.68%
EPS Growth	-57.29%	411.76%	-18.18%	-16.39%	-13.82%	-11.32%	-40.74%	-34.31%	-17.92%	-38.30%	-72.92%
Operating Cash Flow Growth	67.42%	54.58%	-8.94%	-19.38%	-7.93%	-13.92%	-77.08%	37.71%	-38.22%	2.10%	10.12%
Free Cash Flow Firm Growth	106.37%	144.98%	147.48%	154.47%	598.23%	-3.29%	-237.32%	-167.70%	-182.06%	-185.31%	85.45%
Invested Capital Growth	1.52%	-5.00%	-5.34%	-5.49%	-5.66%	-5.37%	11.43%	6.95%	8.71%	7.95%	1.82%
Revenue Q/Q Growth	-1.25%	-3.82%	-2.34%	-1.36%	-0.36%	-4.46%	-1.70%	5.40%	-0.90%	-3.09%	-1.20%
EBITDA Q/Q Growth	0.49%	-11.59%	-12.56%	9.96%	-2.48%	-4.11%	-26.40%	22.30%	10.08%	-11.42%	-35.31%
EBIT Q/Q Growth	0.72%	-15.42%	-14.99%	13.40%	-1.87%	-5.96%	-37.20%	27.90%	13.93%	-17.23%	-50.71%
NOPAT Q/Q Growth	2.03%	-13.98%	-19.42%	15.91%	1.43%	-10.96%	-41.16%	35.13%	21.45%	-30.01%	-59.91%
Net Income Q/Q Growth	-1.16%	-15.32%	-24.25%	23.88%	0.64%	-10.74%	-50.71%	40.19%	30.03%	-33.86%	-78.17%
EPS Q/Q Growth	0.82%	-13.82%	576.47%	25.93%	3.92%	-11.32%	-48.94%	39.58%	29.85%	-33.33%	-77.59%
Operating Cash Flow Q/Q Growth	31.11%	-21.08%	-37.03%	23.74%	49.72%	-26.22%	-83.23%	643.45%	-32.83%	21.93%	-81.92%
Free Cash Flow Firm Q/Q Growth	107.87%	565.28%	-1.16%	5.29%	0.85%	-7.86%	-240.34%	48.09%	-22.25%	4.21%	76.06%
Invested Capital Q/Q Growth	-2.37%	-1.71%	-0.49%	-1.03%	-2.54%	-1.41%	17.17%	-5.01%	-0.94%	-2.09%	10.51%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.87%	28.39%	28.24%	29.10%	29.14%	29.04%	28.44%	28.74%	29.36%	28.93%	27.53%
EBITDA Margin	11.05%	10.16%	9.09%	10.14%	9.92%	9.96%	7.46%	8.65%	9.61%	8.78%	5.75%
Operating Margin	8.83%	7.76%	6.76%	7.77%	7.65%	7.53%	4.81%	5.84%	6.71%	5.73%	2.86%
EBIT Margin	8.83%	7.76%	6.76%	7.77%	7.65%	7.53%	4.81%	5.84%	6.71%	5.73%	2.86%
Profit (Net Income) Margin	5.32%	4.68%	3.63%	4.56%	4.61%	4.30%	2.16%	2.87%	3.77%	2.57%	0.57%
Tax Burden Percent	74.16%	75.41%	71.48%	73.07%	75.52%	71.50%	66.99%	70.77%	75.45%	63.80%	51.89%
Interest Burden Percent	81.24%	79.98%	75.18%	80.35%	79.72%	79.92%	66.95%	69.46%	74.37%	70.28%	38.27%
Effective Tax Rate	25.84%	24.59%	28.52%	26.94%	24.48%	28.50%	33.01%	29.23%	24.55%	36.20%	48.11%
Return on Invested Capital (ROIC)	10.66%	9.22%	7.50%	8.70%	8.90%	8.24%	4.47%	5.90%	7.32%	5.38%	1.92%
ROIC Less NNEP Spread (ROIC-NNEP)	9.11%	7.87%	6.14%	7.45%	7.52%	6.98%	3.51%	4.60%	5.94%	4.22%	1.23%
Return on Net Nonoperating Assets (RNNOA)	4.22%	3.85%	3.00%	3.68%	3.59%	3.21%	2.05%	2.50%	3.14%	2.16%	0.88%
Return on Equity (ROE)	14.89%	13.08%	10.49%	12.38%	12.49%	11.46%	6.53%	8.40%	10.46%	7.54%	2.80%
Cash Return on Invested Capital (CROIC)	8.26%	14.62%	14.66%	14.44%	14.35%	13.81%	-3.80%	-0.07%	-1.89%	-1.71%	2.94%
Operating Return on Assets (OROA)	11.12%	9.69%	8.42%	9.47%	9.15%	8.86%	5.38%	6.53%	7.50%	6.42%	2.95%
Return on Assets (ROA)	6.70%	5.85%	4.53%	5.56%	5.51%	5.06%	2.41%	3.21%	4.21%	2.88%	0.59%
Return on Common Equity (ROCE)	14.89%	13.08%	10.49%	12.38%	12.49%	11.46%	6.53%	8.40%	10.46%	7.54%	2.80%
Return on Equity Simple (ROE_SIMPLE)	11.77%	0.00%	11.17%	10.79%	10.32%	0.00%	8.81%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	73	63	51	59	60	53	31	42	51	36	14
NOPAT Margin	6.55%	5.86%	4.83%	5.68%	5.78%	5.39%	3.22%	4.13%	5.07%	3.66%	1.48%
Net Nonoperating Expense Percent (NNEP)	1.56%	1.36%	1.36%	1.25%	1.37%	1.26%	0.97%	1.30%	1.38%	1.16%	0.69%
Return On Investment Capital (ROIC_SIMPLE)	-	2.15%	-	-	-	1.89%	1.00%	1.39%	1.71%	1.21%	0.44%
Cost of Revenue to Revenue	71.13%	71.61%	71.76%	70.90%	70.86%	70.96%	71.56%	71.26%	70.64%	71.07%	72.47%
SG&A Expenses to Revenue	18.45%	18.96%	20.04%	19.87%	20.13%	20.09%	22.15%	21.24%	20.98%	21.48%	23.17%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	20.04%	20.62%	21.48%	21.33%	21.48%	21.50%	23.63%	22.90%	22.64%	23.19%	24.67%
Earnings before Interest and Taxes (EBIT)	99	83	71	80	79	74	47	60	68	56	28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	123	109	95	105	102	98	72	88	97	86	56
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.07	2.40	2.66	2.24	2.35	2.07	1.53	1.20	1.13	1.14	0.89
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.87	1.02	1.13	0.95	1.00	0.90	0.68	0.55	0.52	0.52	0.40
Price to Earnings (P/E)	17.53	20.45	23.61	20.52	22.36	21.64	17.84	16.01	16.38	17.60	15.99
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.70%	4.89%	4.23%	4.87%	4.47%	4.62%	5.60%	6.25%	6.10%	5.68%	6.26%
Enterprise Value to Invested Capital (EV/IC)	1.73	1.96	2.13	1.83	1.91	1.73	1.30	1.12	1.08	1.09	0.94
Enterprise Value to Revenue (EV/Rev)	1.07	1.21	1.33	1.16	1.20	1.10	0.99	0.81	0.78	0.77	0.73
Enterprise Value to EBITDA (EV/EBITDA)	10.26	11.63	12.92	11.44	12.25	11.26	10.51	9.03	8.75	8.92	8.91
Enterprise Value to EBIT (EV/EBIT)	13.06	14.83	16.60	14.85	16.09	14.82	14.17	12.57	12.54	13.31	13.80
Enterprise Value to NOPAT (EV/NOPAT)	17.85	20.13	22.53	20.16	21.74	20.31	19.55	17.48	17.50	19.07	19.98
Enterprise Value to Operating Cash Flow (EV/OCF)	11.65	11.82	12.95	11.57	12.12	11.28	11.55	8.63	9.56	9.35	8.85
Enterprise Value to Free Cash Flow (EV/FCFF)	21.10	13.07	14.10	12.29	12.92	12.20	0.00	0.00	0.00	0.00	32.18
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.54	0.55	0.56	0.57	0.58	0.58	0.74	0.66	0.64	0.65	0.82
Long-Term Debt to Equity	0.54	0.55	0.56	0.57	0.58	0.58	0.74	0.66	0.64	0.65	0.82
Financial Leverage	0.46	0.49	0.49	0.49	0.48	0.46	0.58	0.54	0.53	0.51	0.72
Leverage Ratio	1.89	1.88	1.85	1.88	1.90	1.90	1.97	1.97	1.98	1.98	2.16
Compound Leverage Factor	1.54	1.50	1.39	1.51	1.52	1.52	1.32	1.37	1.47	1.39	0.83
Debt to Total Capital	35.21%	35.39%	35.76%	36.42%	36.83%	36.78%	42.53%	39.88%	38.87%	39.33%	44.97%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	35.21%	35.39%	35.76%	36.42%	36.83%	36.78%	42.53%	39.88%	38.87%	39.33%	44.97%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.79%	64.61%	64.24%	63.58%	63.17%	63.22%	57.47%	60.12%	61.13%	60.67%	55.03%
Debt to EBITDA	2.20	2.23	2.30	2.39	2.51	2.58	3.52	3.36	3.28	3.40	4.47
Net Debt to EBITDA	1.89	1.85	1.95	2.09	2.11	2.07	3.23	2.97	2.92	2.93	4.03
Long-Term Debt to EBITDA	2.20	2.23	2.30	2.39	2.51	2.58	3.52	3.36	3.28	3.40	4.47
Debt to NOPAT	3.82	3.86	4.01	4.22	4.46	4.65	6.54	6.50	6.55	7.27	10.01
Net Debt to NOPAT	3.29	3.21	3.40	3.68	3.74	3.73	6.01	5.75	5.84	6.27	9.03
Long-Term Debt to NOPAT	3.82	3.86	4.01	4.22	4.46	4.65	6.54	6.50	6.55	7.27	10.01
Altman Z-Score	3.43	3.65	3.80	3.43	3.43	3.25	2.57	2.40	2.37	2.37	1.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.24	2.47	2.51	2.34	2.25	2.50	2.37	2.11	1.99	2.16	2.10
Quick Ratio	2.14	2.33	2.38	2.19	2.11	2.33	2.19	1.91	1.81	1.97	1.92
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	31	208	205	216	218	201	-282	-146	-179	-171	-41
Operating Cash Flow to CapEx	1,505.10%	1,616.67%	678.70%	1,711.32%	1,718.99%	886.73%	164.71%	1,372.53%	705.04%	1,189.53%	196.81%
Free Cash Flow to Firm to Interest Expense	1.69	12.44	11.66	13.68	13.62	13.48	-18.30	-8.04	-10.28	-10.26	-2.40
Operating Cash Flow to Interest Expense	7.97	6.97	4.16	5.74	8.49	6.72	1.09	6.86	4.82	6.13	1.08
Operating Cash Flow Less CapEx to Interest Expense	7.44	6.54	3.55	5.41	7.99	5.97	0.43	6.36	4.14	5.61	0.53
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.25	1.25	1.22	1.20	1.18	1.12	1.12	1.12	1.12	1.03
Accounts Receivable Turnover	5.38	5.58	5.65	5.51	5.62	5.89	5.62	5.67	5.71	6.01	5.49
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	64.26	60.27	56.51	55.09	53.09	50.00	49.43	49.32	49.11	47.64	49.48
Accounts Payable Turnover	97.92	91.64	104.21	129.79	103.15	95.29	113.79	0.00	0.00	76.11	65.07
Days Sales Outstanding (DSO)	67.83	65.41	64.64	66.19	64.96	61.98	64.96	64.38	63.96	60.76	66.47
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	3.73	3.98	3.50	2.81	3.54	3.83	3.21	0.00	0.00	4.80	5.61
Cash Conversion Cycle (CCC)	64.10	61.43	61.14	63.38	61.42	58.15	61.75	64.38	63.96	55.96	60.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,801	2,753	2,739	2,711	2,642	2,605	3,052	2,900	2,872	2,812	3,108
Invested Capital Turnover	1.63	1.58	1.55	1.53	1.54	1.53	1.39	1.43	1.45	1.47	1.29
Increase / (Decrease) in Invested Capital	42	-145	-155	-157	-158	-148	313	189	230	207	55
Enterprise Value (EV)	4,845	5,400	5,823	4,950	5,045	4,512	3,968	3,260	3,113	3,065	2,917
Market Capitalization	3,953	4,539	4,945	4,047	4,177	3,684	2,748	2,187	2,074	2,057	1,599
Book Value per Share	$39.44	$40.09	$40.03	$39.39	$39.61	$40.20	$41.13	$41.71	$41.85	$42.25	$43.32
Tangible Book Value per Share	($10.34)	($10.59)	($11.09)	($12.06)	($12.80)	($12.58)	($19.51)	($18.30)	($17.81)	($18.57)	($26.76)
Total Capital	2,946	2,929	2,898	2,843	2,809	2,810	3,121	3,039	2,999	2,973	3,251
Total Debt	1,038	1,037	1,036	1,035	1,034	1,034	1,327	1,212	1,166	1,169	1,462
Total Long-Term Debt	1,038	1,037	1,036	1,035	1,034	1,034	1,327	1,212	1,166	1,169	1,462
Net Debt	892	861	878	903	868	828	1,220	1,073	1,039	1,008	1,319
Capital Expenditures (CapEx)	9.80	7.20	11	5.30	7.90	11	10	9.10	12	8.60	9.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	405	403	403	392	337	345	401	343	330	331	365
Debt-free Net Working Capital (DFNWC)	551	579	562	524	504	551	508	482	456	492	508
Net Working Capital (NWC)	551	579	562	524	504	551	508	482	456	492	508
Net Nonoperating Expense (NNE)	14	13	13	12	12	11	10	13	13	11	8.87
Net Nonoperating Obligations (NNO)	892	861	878	903	868	828	1,259	1,073	1,039	1,008	1,319
Total Depreciation and Amortization (D&A)	25	26	25	25	23	24	26	29	29	30	28
Debt-free, Cash-free Net Working Capital to Revenue	8.95%	9.06%	9.23%	9.16%	8.05%	8.43%	9.98%	8.56%	8.27%	8.31%	9.16%
Debt-free Net Working Capital to Revenue	12.17%	13.01%	12.85%	12.25%	12.02%	13.43%	12.64%	12.03%	11.44%	12.36%	12.77%
Net Working Capital to Revenue	12.17%	13.01%	12.85%	12.25%	12.02%	13.43%	12.64%	12.03%	11.44%	12.36%	12.77%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.46	$1.08	$0.82	$1.03	$1.07	$0.96	$0.48	$0.67	$0.88	$0.59	$0.13
Adjusted Weighted Average Basic Shares Outstanding	48.10M	48.30M	46.50M	45.70M	44.50M	45.20M	43.70M	43.80M	43.50M	43.40M	41.30M
Adjusted Diluted Earnings per Share	$2.46	$1.06	$0.81	$1.02	$1.06	$0.94	$0.48	$0.67	$0.87	$0.58	$0.13
Adjusted Weighted Average Diluted Shares Outstanding	48.40M	48.70M	46.90M	46.10M	45M	45.70M	44M	44M	43.70M	43.60M	41.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.20M	46.50M	45.90M	44.80M	44.20M	43.60M	43.80M	43.80M	42.70M	41.30M	41M
Normalized Net Operating Profit after Tax (NOPAT)	73	63	51	59	60	53	31	42	51	36	14
Normalized NOPAT Margin	6.55%	5.86%	4.83%	5.68%	5.78%	5.39%	3.22%	4.13%	5.07%	3.66%	1.48%
Pre Tax Income Margin	7.17%	6.21%	5.08%	6.24%	6.10%	6.02%	3.22%	4.06%	4.99%	4.03%	1.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.33	4.99	4.03	5.09	4.93	4.98	3.03	3.27	3.90	3.37	1.62
NOPAT to Interest Expense	3.95	3.77	2.88	3.72	3.72	3.56	2.03	2.32	2.94	2.15	0.84
EBIT Less CapEx to Interest Expense	4.80	4.56	3.41	4.75	4.44	4.22	2.36	2.77	3.22	2.85	1.07
NOPAT Less CapEx to Interest Expense	3.42	3.34	2.27	3.38	3.23	2.80	1.36	1.82	2.26	1.63	0.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	111.98%	124.53%	146.22%	181.74%	195.90%	186.76%	188.54%	142.33%	114.61%	149.87%	161.77%

Financials Breakdown Chart

Key Financial Trends

ASGN Inc. (ASGN) has delivered solid quarterly performance across the last four years, with stable revenue levels, steady profitability, and measurable capital allocation activity. Below are the key takeaways drawn from the quarterly income statements, cash flow statements, and balance sheets for ASGN (through Q4 2025).

Consistent revenue engine with solid margins: Q4 2025 Operating Revenue was 980.1M and Total Revenue matched at 980.1M, with Total Gross Profit of 283.5M (gross margin around 28.9%), implying stable profitability at the operating-gross level.
Strong, positive cash flow from operations: Net cash from continuing operating activities was 102.3M in Q4 2025, 124.9M in Q2 2025, and 83.9M in Q3 2025, with other recent quarters also showing positive cash generation.
Deleveraging trend in 2025: Long-Term Debt declined from about 1.28B in early 2025 to about 1.17B by Q3 2025, alongside quarterly debt repayments (e.g., 143.2M in Q3 2025 and 52.2M in Q4 2025) and selective new borrowings to support buybacks.
Share repurchases show ongoing capital returns: Notable buybacks include approximately 64.2M in Q4 2025 and Q4 2024, along with about 46.2M in Q3 2025, highlighting a consistent buyback program.
Earnings per share remained positive and meaningful: Q3 2025 diluted EPS was 0.87, and Q4 2025 diluted EPS was 0.58, with other quarters showing solid per-share earnings, indicating ongoing profitability per share despite quarterly timing differences.
Balanced balance sheet with a sizable asset base and stable equity: Total assets around 3.70B in 2025 and total equity near 1.83B, with cash around 100–130M across recent quarters, supporting ongoing operations and liquidity.
Moderate, stable capex profile: Quarterly purchases of property, plant & equipment ran roughly in the 8–12M range (example: 8.6M in Q4 2025; 11.9M in Q3 2025; ~9–10M in earlier quarters), indicating steady investment without material capex drag.
Seasonality and quarterly fluctuations: Revenue and earnings show typical seasonality for staffing services, producing visible quarterly swings but a stable annual run-rate over the four-year window.
Financing activities have been a headwind to cash reserves: Net cash from financing activities was negative in several quarters (e.g., around -84.5M in Q3 2025 and -61.2M in Q4 2025), reflecting debt repayments and buybacks that reduce cash on hand.
Significant goodwill and intangible asset base: Goodwill around 2.14B and substantial intangible assets (~470–515M in 2025), which could pose impairment risk if market demand weakens or conditions deteriorate.

05/19/26 01:18 AM ETAI Generated. May Contain Errors.

ASGN Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ASGN's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

ASGN's net income appears to be on an upward trend, with a most recent value of $113.50 million in 2025, rising from $97.65 million in 2015. The previous period was $175.20 million in 2024. See where experts think ASGN is headed by visiting ASGN's forecast page.

ASGN's total operating income in 2025 was $230.30 million, based on the following breakdown:

Total Gross Profit: $1.15 billion
Total Operating Expenses: $918.80 million

Over the last 10 years, ASGN's total revenue changed from $2.07 billion in 2015 to $3.98 billion in 2025, a change of 92.8%.

ASGN's total liabilities were at $1.87 billion at the end of 2025, a 13.4% increase from 2024, and a 90.7% increase since 2015.

In the past 10 years, ASGN's cash and equivalents has ranged from $0.00 in 2016 to $529.60 million in 2021, and is currently $161.20 million as of their latest financial filing in 2025.

Over the last 10 years, ASGN's book value per share changed from 14.86 in 2015 to 42.25 in 2025, a change of 184.2%.

Related Companies

Financial statements for NYSE:EFOR last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASGN (EFOR) Financials

Financials Breakdown Chart

Key Financial Trends

ASGN Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASGN (EFOR) Financials

Annual Income Statements for ASGN

Quarterly Income Statements for ASGN

Annual Cash Flow Statements for ASGN

Quarterly Cash Flow Statements for ASGN

Annual Balance Sheets for ASGN

Quarterly Balance Sheets for ASGN

Annual Metrics And Ratios for ASGN

Quarterly Metrics And Ratios for ASGN

Financials Breakdown Chart

Key Financial Trends

ASGN Financials - Frequently Asked Questions

When does ASGN's financial year end?

How has ASGN's net income changed over the last 10 years?

What is ASGN's operating income?

How has ASGN's revenue changed over the last 10 years?

How much debt does ASGN have?

How much cash does ASGN have?

How has ASGN's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools